Xcout Intel
Remix Therapeutics
Remix Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts. The company specializes in developing novel therapies that alter RNA processing to address serious diseases.
Subscribe to see Remix Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Remix Therapeutics at a glance
Remix Therapeutics is a biotech company headquartered in United States. It has raised at least $164.7M across the 3 funding rounds on record. Its most recent funding round raised $13.7M in December 2023. Xcout tracks 8 named people at Remix Therapeutics, including Peter Smith (Co-Founder, President and Chief Executive Officer). Xcout recorded 12 job postings from Remix Therapeutics in the last 90 days.
Remix Therapeutics leadership
- Peter SmithCo-Founder, President and Chief Executive Officer
- Kevin BittermanDirector
- Matthew PattersonDirector
- Scott BillerDirector
- Linda C. BainAtlas Venture
- Maria KoehlerIndependent
2 more named people on record for Remix Therapeutics, with roles, board committees and tenure — see the full roster →
Remix Therapeutics funding rounds
At least $164.7M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $13.7M | — | |
| Series B | $70M | 1 named | |
| — | $81M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Remix Therapeutics
Xcout recorded 12 job postings from Remix Therapeutics in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Remix Therapeutics's hiring signals →
Recent Remix Therapeutics news
Investors
Tech stack
Remix Therapeutics competitors
A few of Remix Therapeutics's closest competitors — see the full list of competitors and alternatives →
Foghorn Therapeutics is a biopharmaceutical company headquartered in Watertown, Massachusetts. The company is pioneering a new class of medicines that treat serious diseases by leveraging insights into the chromatin regulatory system.
HelixNano is a biotechnology research company headquartered in Boston, Massachusetts, focused on developing advanced mRNA platform technologies for therapeutics.
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
LifeMine Therapeutics is a privately held biotechnology company founded in 2017 with headquarters in Watertown, Massachusetts, and an additional location in Switzerland. The company leverages genomic data to accelerate the discovery and development of novel small-molecule medicines.
Alloy Therapeutics, Inc. is a biotechnology ecosystem company dedicated to democratizing access to antibodies, multispecifics, and genetic modalities, with offices in Waltham and Boston, Massachusetts.
Shape Therapeutics, Inc. is a biotechnology research company founded in 2018 and headquartered in Seattle, Washington. The firm focuses on advancing the future of medicine through programmable RNA technologies and therapeutics.
Get Remix Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Remix Therapeutics in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access